Bellvitge leads the first clinical trial to evaluate antifibrotic benefit in patients with post-COVID fibrosis
The study confirms the improvement in severe lung affectation after COVID-19 thanks to the combination of pirfenidone and corticosteroids.
2025
IDIBELL and Bellvitge Hospital receive funding to improve tolerance in kidney transplants
IDIBELL and the Bellvitge Hospital will promote a new project to improve immune tolerance in kidney transplant patients and reduce the risk of rejection.
Cognitive impairment in lung cancer, an undervalued disorder with new approaches and treatment perspectives
31% of patients already had symptoms of cognitive impairment at the time of lung cancer diagnosis, underscoring the importance of monitoring this disorder to improve patients’ quality of life.
Guided missiles against tumour cells, a possible therapy against pancreatic cancer
Researchers from IDIBELL-CSIC have developed an innovative therapy, based on the use of guided missiles against weak points of pancreatic tumours.
Guided missiles against tumour cells, a possible therapy against pancreatic cancer Read More »
Study reveals worrying exposure of young people to tobacco-related TV content
Massive exposure to tobacco-related images can influence young people’s perceptions of tobacco use, normalizing it and increasing the risk of them starting to smoke.
Study reveals worrying exposure of young people to tobacco-related TV content Read More »
IDIBELL researchers generate heart tissue by 3D bioprinting for the first time
Researchers generate a patch of myocardial tissue by 3D bioprinting that, for the first time, can grow, mature and survive in the long term after being implanted into a host
IDIBELL researchers generate heart tissue by 3D bioprinting for the first time Read More »
Embryos can eliminate bacterial infections before forming their immune system, new research shows
Embryonic cells have been filmed for the first time eliminating bacteria before the immune system forms.
Science and the street meet in Sinergia, the IDIBELL open day
This past Saturday, June 14, science coloured the Bellvitge neighbourhood thanks to Sinergia, the open doors of IDIBELL and the Bellvitge health campus with the support of the City Council of L’Hospitalet del Llobregat. It did so with workshops, organised activities, games, and music to get closer to the residents of the city, inviting them
Science and the street meet in Sinergia, the IDIBELL open day Read More »
From the lab to the hood: Sinergia 2025 brings IDIBELL research closer to the city
Sinergia will open access to the cutting-edge biomedical research carried out by the Bellvitge Biomedical Research Institute (IDIBELL) in L’Hospitalet
From the lab to the hood: Sinergia 2025 brings IDIBELL research closer to the city Read More »
Key regions of DNA and genes that trigger liver regeneration have been identified
A genomic-scale map of the interactions between the regulatory elements of liver regeneration and the key genes involved is drawn
Key regions of DNA and genes that trigger liver regeneration have been identified Read More »